Hotchkis & Wiley Capital Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.37M | Buy |
111,950
+10,310
| +10% | +$587K | 0.02% | 359 |
|
2025
Q1 | $5.7M | Buy |
101,640
+26,460
| +35% | +$1.48M | 0.02% | 358 |
|
2024
Q4 | $4.62M | Sell |
75,180
-13,830
| -16% | -$850K | 0.02% | 396 |
|
2024
Q3 | $5.96M | Buy |
89,010
+50,030
| +128% | +$3.35M | 0.02% | 373 |
|
2024
Q2 | $2.6M | Buy |
38,980
+3,360
| +9% | +$224K | 0.01% | 459 |
|
2024
Q1 | $2.53M | Buy |
+35,620
| New | +$2.53M | 0.01% | 458 |
|